Kalpana Gupta, MD

VA Boston, Boston, MA, USA

Disclosure(s): GlaxoSmithKline: Advisor/Consultant; IDSA GL on UTI: Uncompensated author; Iterum Therapeutics: Advisor/Consultant; PhenUtest Diagnostics: Advisor/Consultant; Qiagen Inc.,: Advisor/Consultant; UpToDate: Royalties for UTI topics; Utility Therapeutics Ltd: Advisor/Consultant

Poster(s):

• (P-1092) Re-analysis of Pivmecillinam Randomized Clinical Trial Data According to 2019 US Food and Drug Administration Guidance for the Treatment of Uncomplicated Urinary Tract Infection
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT